Jiang XY - Search Results

1

Tumor targeted self-synergistic nanoplatforms for arsenic-sensitized photodynamic therapy.

Yuan P, Fan GL, Zhao LP, Liu LS, Deng FA, Jiang XY, Hu AH, Yu XY, Chen AL, Cheng H, Li SY. Yuan P, et al. Among authors: jiang xy. Acta Biomater. 2020 Nov;117:349-360. doi: 10.1016/j.actbio.2020.09.047. Epub 2020 Sep 30. Acta Biomater. 2020. PMID: 33010514

2

Inhibition of Gata4 and Tbx5 by Nicotine-Mediated DNA Methylation in Myocardial Differentiation.

Jiang XY, Feng YL, Ye LT, Li XH, Feng J, Zhang MZ, Shelat HS, Wassler M, Li Y, Geng YJ, Yu XY. Jiang XY, et al. Stem Cell Reports. 2017 Feb 14;8(2):290-304. doi: 10.1016/j.stemcr.2016.12.016. Epub 2017 Jan 19. Stem Cell Reports. 2017. PMID: 28111280 Free PMC article.

3

Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools.

Li SP, Lin ZX, Jiang XY, Yu XY. Li SP, et al. Among authors: jiang xy. Acta Pharmacol Sin. 2018 Apr;39(4):542-551. doi: 10.1038/aps.2017.178. Epub 2018 Jan 25. Acta Pharmacol Sin. 2018. PMID: 29417947 Free PMC article. Review.

4

An azobenzene-based heteromeric prodrug for hypoxia-activated chemotherapy by regulating subcellular localization.

Li S , Jiang X , Zheng R , Zuo S , Zhao L , Fan G , Fan J , Liao Y , Yu X , Cheng H . Li S , et al. Chem Commun (Camb). 2018 Jul 12;54(57):7983-7986. doi: 10.1039/c8cc03430c. Chem Commun (Camb). 2018. PMID: 29963672

5

Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy.

Cheng H, Zheng RR, Fan GL, Fan JH, Zhao LP, Jiang XY, Yang B, Yu XY, Li SY, Zhang XZ. Cheng H, et al. Among authors: jiang xy. Biomaterials. 2019 Jan;188:1-11. doi: 10.1016/j.biomaterials.2018.10.005. Epub 2018 Oct 5. Biomaterials. 2019. PMID: 30312907

6

A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy.

Cheng H, Jiang XY, Zheng RR, Zuo SJ, Zhao LP, Fan GL, Xie BR, Yu XY, Li SY, Zhang XZ. Cheng H, et al. Among authors: jiang xy. Biomaterials. 2019 Mar;195:75-85. doi: 10.1016/j.biomaterials.2019.01.003. Epub 2019 Jan 3. Biomaterials. 2019. PMID: 30616030

7

Lineage reprogramming of fibroblasts into induced cardiac progenitor cells by CRISPR/Cas9-based transcriptional activators.

Wang J, Jiang X, Zhao L, Zuo S, Chen X, Zhang L, Lin Z, Zhao X, Qin Y, Zhou X, Yu XY. Wang J, et al. Among authors: jiang x. Acta Pharm Sin B. 2020 Feb;10(2):313-326. doi: 10.1016/j.apsb.2019.09.003. Epub 2019 Sep 17. Acta Pharm Sin B. 2020. PMID: 32082976 Free PMC article.

8

Self-delivery nanomedicine to overcome drug resistance for synergistic chemotherapy.

Zheng RR, Zhao LP, Liu LS, Deng FA, Chen XY, Jiang XY, Wang C, Yu XY, Cheng H, Li SY. Zheng RR, et al. Among authors: jiang xy. Biomater Sci. 2021 May 4;9(9):3445-3452. doi: 10.1039/d1bm00119a. Biomater Sci. 2021. PMID: 33949456

9

Self-delivery nanomedicine for vascular disruption-supplemented chemo-photodynamic tumor therapy.

Liu Y, Deng F, Zheng R, Chen X, Zhao L, Yu B, Chen A, Jiang X, Cheng H, Li S. Liu Y, et al. J Colloid Interface Sci. 2022 Apr 15;612:562-571. doi: 10.1016/j.jcis.2021.12.128. Epub 2021 Dec 24. J Colloid Interface Sci. 2022. PMID: 35026565

10

BRD9 controls the oxytocin signaling pathway in gastric cancer via CANA2D4, CALML6, GNAO1, and KCNJ5.

Wang Y, Jiang XY, Yu XY. Wang Y, et al. Among authors: jiang xy. Transl Cancer Res. 2020 May;9(5):3354-3366. doi: 10.21037/tcr.2020.03.67. Transl Cancer Res. 2020. PMID: 35117701 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters